Covid-19: Working with govt to ensure smooth supply of medicines, says IPA

The member companies are closely monitoring orders and inventories of medicines

The Indian Pharmaceutical Alliance (IPA) on Saturday said it along with its member companies is working with the government, various pharma industry associations in India and other key stakeholders in the pharmaceutical supply chain to ensure that patients in India and the world continue to have access to medicines.

The member companies are closely monitoring orders and inventories of medicines, it said.

"With an adequate stock of Active Pharmaceutical Ingredients (APIs), finished product formulations and channel availability, we would be able to sustain the supply of medicines for the coming months, the IPA said in a statement.

The pharma industry body also said that it is not aware of any medicines shortage, to date.

"We are working closely with the International Generic and Biosimilar Medicines Association (IGPA), World Health Organisation (WHO) headquarters in Switzerland and its India office, Association of Affordable Medicines (AAM) USA, Medicines for Europe and several other country associations to assess international developments and any potential impact on supply of medicines globally," the IPA said.

The IPA and its companies are aligned to government initiatives of containment measures and social distancing while meeting supply commitments in the essential services for availability of medicines, it added.

The IPA is committed to providing quality medicines to patients in India and across globe as patient centricity and welfare is fundamental to us, the statement said.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel